PLX
Price
$1.54
Change
-$0.05 (-3.14%)
Updated
Sep 5 closing price
Capitalization
122.79M
72 days until earnings call
SRRK
Price
$31.41
Change
-$1.03 (-3.18%)
Updated
Sep 5 closing price
Capitalization
3.02B
72 days until earnings call
Interact to see
Advertisement

PLX vs SRRK

Header iconPLX vs SRRK Comparison
Open Charts PLX vs SRRKBanner chart's image
Protalix BioTherapeutics
Price$1.54
Change-$0.05 (-3.14%)
Volume$1.2M
Capitalization122.79M
Scholar Rock Holding
Price$31.41
Change-$1.03 (-3.18%)
Volume$2.11M
Capitalization3.02B
PLX vs SRRK Comparison Chart in %
Loading...
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PLX vs. SRRK commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLX is a Hold and SRRK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (PLX: $1.54 vs. SRRK: $31.41)
Brand notoriety: PLX and SRRK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLX: 199% vs. SRRK: 133%
Market capitalization -- PLX: $122.79M vs. SRRK: $3.02B
PLX [@Biotechnology] is valued at $122.79M. SRRK’s [@Biotechnology] market capitalization is $3.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLX’s FA Score shows that 0 FA rating(s) are green whileSRRK’s FA Score has 0 green FA rating(s).

  • PLX’s FA Score: 0 green, 5 red.
  • SRRK’s FA Score: 0 green, 5 red.
According to our system of comparison, SRRK is a better buy in the long-term than PLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLX’s TA Score shows that 4 TA indicator(s) are bullish while SRRK’s TA Score has 4 bullish TA indicator(s).

  • PLX’s TA Score: 4 bullish, 5 bearish.
  • SRRK’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, PLX is a better buy in the short-term than SRRK.

Price Growth

PLX (@Biotechnology) experienced а -0.65% price change this week, while SRRK (@Biotechnology) price change was -3.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

PLX is expected to report earnings on Nov 17, 2025.

SRRK is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRRK($3.02B) has a higher market cap than PLX($123M). PLX YTD gains are higher at: -18.085 vs. SRRK (-27.325). PLX has higher annual earnings (EBITDA): 10.4M vs. SRRK (-320.22M). SRRK has more cash in the bank: 295M vs. PLX (33.4M). PLX has less debt than SRRK: PLX (5.35M) vs SRRK (61.5M). PLX has higher revenues than SRRK: PLX (61.9M) vs SRRK (0).
PLXSRRKPLX / SRRK
Capitalization123M3.02B4%
EBITDA10.4M-320.22M-3%
Gain YTD-18.085-27.32566%
P/E Ratio17.11N/A-
Revenue61.9M0-
Total Cash33.4M295M11%
Total Debt5.35M61.5M9%
FUNDAMENTALS RATINGS
PLX vs SRRK: Fundamental Ratings
PLX
SRRK
OUTLOOK RATING
1..100
768
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
65
Fair valued
PROFIT vs RISK RATING
1..100
10078
SMR RATING
1..100
5399
PRICE GROWTH RATING
1..100
5140
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PLX's Valuation (52) in the Servicestothe Health Industry industry is in the same range as SRRK (65) in the Biotechnology industry. This means that PLX’s stock grew similarly to SRRK’s over the last 12 months.

SRRK's Profit vs Risk Rating (78) in the Biotechnology industry is in the same range as PLX (100) in the Servicestothe Health Industry industry. This means that SRRK’s stock grew similarly to PLX’s over the last 12 months.

PLX's SMR Rating (53) in the Servicestothe Health Industry industry is somewhat better than the same rating for SRRK (99) in the Biotechnology industry. This means that PLX’s stock grew somewhat faster than SRRK’s over the last 12 months.

SRRK's Price Growth Rating (40) in the Biotechnology industry is in the same range as PLX (51) in the Servicestothe Health Industry industry. This means that SRRK’s stock grew similarly to PLX’s over the last 12 months.

PLX's P/E Growth Rating (98) in the Servicestothe Health Industry industry is in the same range as SRRK (100) in the Biotechnology industry. This means that PLX’s stock grew similarly to SRRK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PLXSRRK
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 16 days ago
84%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CABGY24.520.12
+0.49%
Carlsberg AS
EMFGF0.05N/A
N/A
Fluence Corp Ltd.
RUBSF33.31N/A
N/A
RUBIS
IMMQF3.46N/A
N/A
IMMOBILIARE GRANDE DISTRIBUZIONE SIIQ SPA
SMRVF0.07-0.01
-6.67%
Smooth Rock Ventures Corp.

PLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLX has been loosely correlated with IOVA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PLX jumps, then IOVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLX
1D Price
Change %
PLX100%
-3.14%
IOVA - PLX
46%
Loosely correlated
+13.18%
SRRK - PLX
32%
Poorly correlated
-3.18%
CDIO - PLX
30%
Poorly correlated
+0.60%
SNDX - PLX
30%
Poorly correlated
+5.25%
DNA - PLX
29%
Poorly correlated
-4.54%
More

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with PLRX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
-3.18%
PLRX - SRRK
40%
Loosely correlated
+14.11%
SNDX - SRRK
39%
Loosely correlated
+5.25%
VTGN - SRRK
39%
Loosely correlated
-1.93%
ENTO - SRRK
38%
Loosely correlated
+1.89%
ALT - SRRK
37%
Loosely correlated
+6.18%
More